Abstract : The global issue of counterfeit drugs is a growing concern, affecting every country and posing a significant threat, especially to lower-income and lower-middle-income countries. While there isn't a universally agreed-upon definition of counterfeit medicines, the World Health Organization's widely accepted definition from 1992 characterizes them as intentionally and fraudulently mislabeled concerning identity and/or source. Counterfeit products can vary, including those with correct ingredients, incorrect ingredients, no active ingredients, insufficient active ingredients, or fake packaging. Recent WHO estimates indicate that approximately 1 in 10 medicinal products circulating in low- and middle-income countries is either substandard or falsified.
Keywords :
Cite : Johar, P. K., & Singh, J. (2024). Blockchain-Based Solution For Tackling Counterfeit Drugs In India (1st ed., pp. 26-31). Noble Science Press. https://doi.org/10.52458/9788197040887.2024.eb.ch-06
References :
World Health Organization. (2017). 1 in 10 medical products in developing countries is substandard or falsified.
Food and Drug Administration. Reporting serious problems to FDA. www.fda.gov/Safety/MedWatch/HowToReport/default.htm, January 6, 2011. Accessed March 29, 2014.
Chambliss, W. G., Carroll, W. A., Kennedy, D., Levine, D., Moné, M. A., Ried, L. D., ... & Yelvigi, M. (2012). Role of the pharmacist in preventing distribution of counterfeit medications. Journal of the American Pharmacists Association, 52(2), 195-199.
Snyder, M. (2016). Keeping Counterfeit Medicines Out of the Supply Chain. Pharmaceutical Processing World, 28.
Ashima G. Siraj, Pharma Secure: Fighting fake drugs in India, August 2012.
